LGC LGC
  • About us
    • About LGC
    • Leadership team
    • Our locations
    • ESG
    • Reports & documents
  • What we do
    • Diagnostics and Genomics
      • Clinical diagnostics
      • Biosearch Technologies
    • Assurance
      • Reference standards, research chemicals & proficiency testing
      • Supply chain assurance
      • National Laboratories & Science
    • Nucleic Acid Therapeutics
      • Axolabs
  • Careers
    • Our people
    • Careers at LGC
  • News
  • Contact us
Buy from us

Follow us on social media

News

To contact the press office please email or call +44 7408 850 514

LGC’s multi-allergen reference material kit awarded ISO 17034 accreditation

16 October 2020

LGC is delighted that the production of its first ever multi-allergen reference material kit containing five common allergens (milk, egg, almond, hazelnut, walnut), traceable to the SI (International System of Units), has been confirmed within the scope of its ISO 17034 accreditation.

Read More
Celebrating Ada Lovelace Day with Lester W Strock award winner Heidi Goenaga-Infante

13 October 2020

Ada Lovelace Day (13 Oct) is an international celebration of the achievements of women in science, technology, engineering and maths.

Read More
Selvarani Elahi awarded MBE in Queen’s Birthday Honours List 2020

12 October 2020

Deputy Government Chemist and Business Manager, Food Research, LGC, awarded MBE for services to Food Measurement Science

Read More
LGC makes top 40 in Sunday Times’ business rankings

09 October 2020

The Sunday Times Grant Thornton Top Track 250 league table ranks Britain’s private mid-market growth companies with the biggest sales.

Read More
LGC makes top 25 in Sunday Times’ business rankings

30 September 2020

LGC remains the highest ranked life sciences company in the league table.

Read More
LGC releases SARS-CoV-2 & influenza multiplexed molecular quality solutions

29 September 2020

Kit designed to measure day-to-day performance of the assay providing positive and negative reference solution.

Read More
LGC COVID-19 antibody assay processes up to 40,000 tests per day in UK

23 September 2020

First commercially cvailable SARS-CoV-2 antibody test in UK compatible with Neoteryx’s Mitra® Microsampling Device for at-home blood collection

Read More
LGC announces new senior appointments

17 September 2020

LGC has announced three new senior appointments

Read More
Measurement for Recovery (M4R) launched to boost UK innovation

27 August 2020

M4R will run until the end of 2020 and will enable businesses to have access to the world-leading chemical and bio-measurement expertise and capabilities at the NML.

Read More
LGC and Aptahem combine on first large-scale production campaign of Apta-1

13 August 2020

First large-scale production run of Apta-1as a non-GMP material, intended for use in GLP toxicology studies

Read More
Kent consortium gets green light to develop £60million investment bid: proposal to accelerate medicines development via data and digital technology

11 August 2020

A proposal that could bring £60million investment into the life sciences sector in Kent has taken a significant stride forward by securing £50,000 to develop the bid further. The money is seedcorn funding via UK Research and Innovation’s flagship £236m Strength in Places Fund.

Read More
LGC SeraCare SARS-CoV-2 Molecular Controls Kit now CE-Marked

28 July 2020

Bearing the CE mark and IVD symbol signifies that the AccuPlex SARS-CoV-2 Molecular Controls Kit meets extensive design control requirements.

Read More
  • PREV
  • 1
  • …
  • 9
  • 10
  • 11
  • …
  • 19
  • NEXT
LGC LGC

Contact us

Follow us on social media

About us
  • About LGC
  • Our locations
  • Leadership team
  • ESG
  • Reports & documents
What we do
  • Clinical diagnostics
  • Biosearch technologies
  • Reference standards, research chemicals & proficiency testing
  • Nucleic acid therapeutic services
  • Supply chain assurance
  • National Laboratories & Science
Policies
  • Terms and conditions
  • Privacy notice
  • Cookie policy
  • Data privacy and processing Policy
  • LGC modern slavery statement
Careers
  • Careers at LGC
  • Our people
  • News
  • Contact us

© LGC Limited, 2025.
All rights reserved. All trademarks acknowledged.

LGC Limited Registered in England No. 2991879. VAT No. 674 056 721
Registered office: LGC, Queens Road, Teddington, Middlesex, TW11 0LY, UK

Manage Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage {vendor_count} vendors Read more about these purposes
View preferences
{title} {title} {title}